Established in 2007, Olympian Clinical Research’s mission is to set the standard in performing clinical research trials according to FDA and ICH GCP guidelines. Olympian Clinical Research recognizes that research studies are fundamental in the development of new drugs and generic alternatives of established drugs. Our group primarily conducts phase II & III clinical trials in both adult and pediatric patients. Medications studied in these phases have already been assessed for safety and proper dosages in Phase I. Clinical research studies the efficacy both short and long term of new treatment options being developed.